Form 4 for PCVX Vaxcyte, Inc.
Accepted 2023-01-04 00:00:00 ET · period of report 2022-12-30 · accession 0001209191-23-000943 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-04 | 2022-12-30 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $2.03 | +15.2K | 374.5K | +4% | +$30.8K |
| D | 2023-01-04 | 2022-12-30 | PCVX | PICKERING GRANT | CEO, Dir | A - Grant | $0.00 | +108.2K | 108.2K | New | $0 |
| D | 2023-01-04 | 2022-12-30 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -15.2K | 302.2K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-30 | M | A | 15,158 | $2.03 | 374,476 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-12-30 | A | A | 108,250 | $0.00 | 108,250 | D | $47.95 · — to 2032-12-30 | 108,250 Common Stock | (F3) 1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
| 3 | Derivative | Stock Option (right to buy) | 2022-12-30 | M | D | 15,158 | $0.00 | 302,227 | D | $2.03 · — to 2028-07-23 | 15,158 Common Stock | (F4) Stock Option is fully vested and exercisable. |